With over thirty years’ experience in healthcare administration, Dr. Scott Rocklage is a person to esteem and learn important life skills to make one successful. His expertise and remarkable leadership skills helped him gain approval of new drugs; Teslascan, Cubicin, and Omniscan. Learn more: http://5amventures.com/team/scott-m-rocklage-phd/
Scott’s education background.
Scott Rocklage was awarded a bachelors degree in chemistry from the University of California, he then attained his Ph.D. in chemistry from the Massachusetts Institute of Technology (MIT).
His career journey.
Dr.Scott has served as the CEO and chairperson of Cubist Pharmaceuticals, later on, he joined Nycomed Salutar and was appointed as the president as well as the CEO, Scott has served in many organizations as the board chairman.
Currently, Scott serves as Board Chairman in several organizations; Rennovia, Kinestral, and Cidara later in 2003 he joined 5 AM ventures.
Scott’s most current career move was joining expansion therapeutics in January 2018 as a founding member and chairman of the board of directors.
Expansion therapeutics is involved with developing and discovering drugs, the company’s main aim is to unveil the power of molecule medicines. Some of the main genetic diseases that have stirred the search for therapies and treatments include; myotonic dystrophy type I also known as DM1. This disease mostly affects adults.
To achieve success in fighting the disease, the company dedicated approximately $55.3 million, DM1 is a risky condition as it can affect an entire family, it also gets worse with the succeeding generation, and it is because of this factor that expansion therapeutics are creating medications that will help address the condition.
As the chairman of the board and a founding member of expansion therapeutics, Scott released a statement saying their lead scientist was working effortlessly to come up with a solution for the disease.
Matthew D. Disney backed Scott’s statement and confirmed that together with his team they were proud and happy to reveal that they had developed a therapy over the past 12 years and this was a significant step, Mr. Disney also vowed that his team would not stop working until the best remedy is achieved.
Hearing such words from the lead scientists in finding the cure is encouraging, now all we can do is wait and hope that all goes well.